Prevalence of eye disease in Brazilian patients with psoriatic arthritis

Clinics

Volumn 67, Issue 3, 2012, Pages 249-253

  de Lima, Fernanda B F ^a   Abalem, Maria Fernanda ^a   Ruiz, Danilo G ^a   Gomes, Beatriz de A F ^a   de Azevedo, Mário N L ^a   Moraes, Haroldo V ^a   Yeskel, Ariyah Seth ^a   Kara, Kara Newton ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Eye; Keratoconjunctivitis sicca; Ocular findings; Psoriatic arthritis

Indexed keywords

ARTICLE; BRAZIL; EPIDEMIOLOGY; FEMALE; HUMAN; KERATOCONJUNCTIVITIS SICCA; MALE; MIDDLE AGED; PSORIATIC ARTHRITIS;

ARTHRITIS, PSORIATIC; BRAZIL; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; KERATOCONJUNCTIVITIS SICCA; MALE; MIDDLE AGED;

EID: 84859545363     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.6061/clinics/2012(03)08     Document Type: Article

References (43)

1. Moll JM, Wright V. Psoriatic arthritis. Semin Arthritis Rheum. 1973;3(1):55-78, http://dx.doi.org/10.1016/0049-0172(73)90035-8.
2. Gladman DD. Psoriatic arthritis. Dermatol Ther. 2009;22(1):40-55, http://dx.doi.org/10.1111/j.1529-8019.2008.01215.x.
3. Jamshidi F, Bouzari N, Seirafi H, Farnaghi F, Firooz A. The prevalence of psoriatic arthritis in psoriatic patients in Tehran, Iran. Arch Iran Med. 2008;11(2):162-165.
4. Zachariae H. Prevalence of Joint Disease in Patients with Psoriasis: Implications for Therapy. Am J Clin Dermatol. 2003;4(7):441-447, http://dx.doi.org/10.2165/00128071-200304070-00001.
5. Gladman DD, Antoni C, Mease P, Clegg DO, Nash P. Psoriatic arthritis: epidemiology, clinical features, course, and outcome. Ann Rheum Dis. 2005;64 Suppl 2:ii14-ii17.
6. Queiro R, Sarasqueta C, Belzunegui J, Gonzales C, Figueroa M, Torre-Alonso JC. Psoriatic Spondyloarthropathy: A comparative study between HLA-B27 positive and HLA-B27 negative disease. Semin Arthiritis Rheum. 2002;31(6):413-41 http://dx.doi.org/10.1053/sarh.2002.33470.
7. Banãres A, Hernández-Garcia C, Fernández-Gutiérrez B, Jover JA. Eye involvement in the Spondyloarthropathies. Rheum Dis Clin North Am. 1998;24(4):771-784, 9, http://dx.doi.org/10.1016/S0889-857X(05)70041-7.
8. Lambert JR, Wright V. Eye inflammation in psoriatic arthritis. Ann Rheum Dis. 1976;35(4):354-356, http://dx.doi.org/10.1136/ard.35.4.354.
9. Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H. CASPAR Study Group Classification Criteria for Psoriatic Arthritis: development of new criteria from a large internacional study. Arthritis Rheum. 2006;54(8):2265-2673.
10. Chylack LT, Wolfe JK, Singer DM, Leske MC, Bullimore MA, Bailey IL, et al. The lens Opacities Classification System III.The Longitudinal Study of Cataract Study Group. Arch Ophthalmol. 1993;111(6):831-836, http://dx.doi.org/10.1001/archopht.1993.01090060119035.
11. Sullivan BD, Whitmer D, Nichols KK, Tomlinson A, Foulks GN, Geerling G, et al. An Objective Approach to Dry Eye Disease Severity. Invest Ophthalmol Vis Sci. 2010;51(12):6125-6130, http://dx.doi.org/10.1167/iovs.10-5390.
12. van Bijsterveld OP. Diagnostic tests in the Sicca syndrome. Arch Ophthalmol. 1969;82(1):10-14, http://dx.doi.org/10.1001/archopht.1969.00990020012003.
13. Subcommittee of the international dry eye workshop. Methodologies to diagnose and monitor dry eye disease: report of the diagnostic methodology subcommittee of the international dry eye workshop. Ocul Surf. 2007;5(2):108-152.
14. Schiffman MS, Christianson FR, Jacobsen G, Hirsch JD, Reis BL. Reliability and Validity of the Ocular Surface Disease Index. Arch Ophthalmol. 2000; 118(5):615-621.
15. Wolfs RC, Borges PH, Ramrattan RS, Klaver CC, Hulsman CA, Holfman A, et al. Changing Views on Open-Angle Glaucoma: Definitions and Prevalence- The Rotterdam Study. Invest Ophthalmol Vis Sci. 2000; 41(11):3309-3321.
16. Reich K, Kruger K, Mossner R, Augustin M. Epidemiological and clinical pattern of psoriatic arthritis in Germany: a prospective interdisciplinary epidemiological study of 1511 patients with plaque-type psoriasis. Br J Dermatol. 2009;160(5):1040-1047, http://dx.doi.org/10.1111/j.1365-2133.2008.09023.x.
17. Mahugh NJ, Balachrishnan C, Jones SM. Progression of peripheral joint disease in psoriatic arthritis: a 5-yr prospective study. Rheumatology. 2003;42(6):778-783, http://dx.doi.org/10.1093/rheumatology/keg217.
18. Paiva ES, Macaluso DC, Edwards A, Rosenbaum JT. Characterization of uveitis in patients with psoriatic arthritis. Ann Rheum Dis. 2000;59(1):67-70, http://dx.doi.org/10.1136/ard.59.1.67.
19. Sampaio-Barros P, Conde RA, Bonfiglioli R, Bértolo MB, Samara AM. Characterization and outcome of uveitis in 350 patients with spondyloarthropathies. Rheumatol Int. 2006;26(12):1143-1146, http://dx.doi.org/10.1007/s00296-006-0203-7.
20. Gouveia EB, Yamamoto JH, Abdalla M, Hirata CE, Kubo P, Olivalves E. Causes of uveitis in a tertiary center in Sao Paulo city, Brazil. Arq Bras Ophthalmol. 2004;67:139-145, http://dx.doi.org/10.1590/S0004-27492004000100025.
21. Queiro R, Torre JC, Belzunegui J, Gonzales C, Dios JR, Unanue F, et al. Clinical Features and Predictive Factors in Psoriatic Arthritis- Related uveitis. Semin Arthritis Rheum. 2002;31(4):264-270, http://dx.doi.org/10.1053/sarh.2002.28798.
22. Zeboulon N, Dougados M, Gossec L. Prevalence and characteristics of uveitis in the spondyloarthropathies: a systematic literature review. Ann Rheum Dis. 2008;67(7):955-959.
23. Cantini F, Niccoli L, Nannini C, Kaloudi O, Bertoni M, Cassara E. Psoriatic arthritis: a systematic review. In J Rheum Dis. 2010;13(4):300-317. doi:10.1111/j.1756-185X.2010.01540.x.
24. Lim LL, Fraunfelder FW, Rosenbaum JT. Do tumor necrosis factor inhibitors cause uveitis? A registry-based study. Arthritis Rheum. 2007;56(10):3248-3252.
25. Kakkassery V, Mergler S, Pleyer U. Anti-TNF-alpha treatment: a possible promoter in endogenous uveitis? observational report on six patients: occurrence of uveitis following etanercept treatment. Curr Eye Res. 2010;35(8):751-756, http://dx.doi.org/10.3109/02713683.2010.486520.
26. Vitali C, Bombardieiri S, Jonnson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002;61(6):554-558, http://dx.doi.org/10.1136/ard.61.6.554.
27. Scotto di Fazano CS, Grilo RM, Vergne P, Coyral D, Inoui R, Bonnet C, et al. Is the relationship between spondyloarthropathies and Sjogren's syndrome in women coincidental? a study of 13 cases. Joint Bone Spine. 2002;69(4):383-387, http://dx.doi.org/10.1016/S1297-319X(02)00414-1.
28. Nichols KK, Nichols JJ, Mitchell GL. The Lack of Association Between Signs and Symptoms in Patients With Dry Eye Disease. Cornea. 2004;23(8):762-770, http://dx.doi.org/10.1097/01.ico.0000133997.07144.9e.
29. Lemp MA. Dry Eye (Keratoconjunctivitis Sicca), Rheumatoid Arthritis, and Sjögren's Syndrome. Am J Ophthalmol. 2005;140(5):898-899, http://dx.doi.org/10.1016/j.ajo.2005.06.031.
30. Fujita M, Igarashi T, Kurai T, Sakane M, Yoshino S, Takahashi H. Correlation between dry eye and rheumatoid arthritis activity. Am J Ophthalmol. 2005;140(5):808-813, http://dx.doi.org/10.1016/j.ajo.2005.05.025.
31. Lemp MA, Nichols KK. Blepharitis in the United States 2009: a surveybased perspective on prevalence and treatment. Ocul Surf. 2009:7(2 Suppl):S1-S14.
32. Paula JS, Thorn F, Cruz AA. Prevalence of pterygium and cataract in indigenous populations of the Brazilian Amazon rain forest. Eye. 2006;20(5):533-536, http://dx.doi.org/10.1038/sj.eye.6701917.
33. Sharma S. Keratitis. Biosci Rep. 2001;21(4):419-444, http://dx.doi.org/10.1023/A:1017939725776.
34. James ER. The etiology of steroid cataract. J Ocul Pharmacol Ther. 2007;23(5):403-420, http://dx.doi.org/10.1089/jop.2006.0067.
35. Hamideh F, Prete PE. Ophthalmologic Manifestations of Rheumatic Diseases. Semin Arthritis Rheum. 2001;30(4):217-241, http://dx.doi.org/10.1053/sarh.2001.16639.
36. Klein R, Klein BE, Moss SE, Wang Q. Hypertension and retinopathy,arteriolar narrowing, and arteriovenous nicking in a population. Arch Ophthalmol. 1994;112(1):92-98, http://dx.doi.org/10.1001/archopht.1994.01090130102026.
37. Wong TY, Mitchell P. The eye in hypertension. Lancet. 2007;3;369 (9559):425-435.
38. Mease PJ. Tumor Necrosis Factor (TNF) in psoriatic arthritis: pathophysiology and treatment with TNF inhibitors. Ann Rheum Dis. 2002;61(4):298-2304, http://dx.doi.org/10.1136/ard.61.4.298.
39. Mease PJ, Goffe BS, Metz J, Vanderstoep A, Finck B, Burge DJ. Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomized trial. The Lancet. 2000;356(9227):385-390, http://dx.doi.org/10.1016/S0140-6736(00)02530-7.
40. Smith JR, Levinson RD, Holland GN, Jabs DA, Robinson MR, Whitcup SM, et al. Differential efficacy of Tumor Necrosis Factor Inhibition in the management of inflammatory eye disease and associated rheumatic disease. Arthritis Rheum. 2001;45(3):252-257, http://dx.doi.org/10.1002/1529-0131(200106)45:3,252::AID-ART257.3.0.CO;2 -5.
41. El-Shabrawi Y, Hermann J. Anti-tumor Necrosis Factor-alpha Therapy with Infliximab as an alternative to corticosteroids in the treatment of human leukocyte antigen B27-associated acute anterior uveitis. Ophthalmology. 2002;109(12):2342-2346, http://dx.doi.org/10.1016/S0161-6420(02)01292-7.
42. Elman A, Gullberg R, Nilsson E, Rendahl I, Wachtmeister L. Cloroquine retinopathy in patients with rheumatoid arthritis. Scand J Rheumatol. 1976; 5(3):161-166, http://dx.doi.org/10.3109/03009747609165456.
43. Montaudie H, Sbidian E, Paul C, Maza A, Gallini A, Aractingi S, et al. Methotrexate in psoriasis: a systematic review of treatment modalities, incidence, risk factors and monitoring of liver toxicity. J Eur Acad Dermatol Venerol. 2011 May;25(Suppl2):12-128, http://dx.doi.org/10.1111/j.1468-3083.2011.03991.x.